Infinity Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Infinity Pharmaceuticals, Inc.‘s stocks are currently a part of 30 hedge funds’ portfolios, which represents 5.36% of the total amount of its stocks outstanding. This makes up a total of 4.78M shares of Infinity Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -80.93% or -20.28M shares fewer. As for the holding position changes, 26.67% (8) of current hedge fund investors increased the number of shares held, 16.67% (5) of current holders sold a part of the shares held, and 40% (12) closed the holdings completely. 1 hedge funds are new holders of Infinity Pharmaceuticals, Inc. stock in Q1 2023, it is 3.33% of total holders.
Hedge funds holding Infinity Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 61 |
|---|---|
| Q3 2018 | 61 |
| Q4 2018 | 61 |
| Q1 2019 | 61 |
| Q2 2019 | 54 |
| Q3 2019 | 50 |
| Q4 2019 | 44 |
| Q1 2020 | 46 |
| Q2 2020 | 43 |
| Q3 2020 | 41 |
| Q4 2020 | 52 |
| Q1 2021 | 81 |
| Q2 2021 | 95 |
| Q3 2021 | 103 |
| Q4 2021 | 94 |
| Q1 2022 | 86 |
| Q2 2022 | 68 |
| Q3 2022 | 70 |
| Q4 2022 | 63 |
| Q1 2023 | 30 |
Hedge funds changes in Infinity Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 14 | 15 | 14 | 16 | 2 |
|---|---|---|---|---|---|
| Q3 2018 | 11 | 15 | 16 | 11 | 8 |
| Q4 2018 | 15 | 16 | 13 | 15 | 2 |
| Q1 2019 | 9 | 14 | 17 | 9 | 12 |
| Q2 2019 | 7 | 9 | 12 | 14 | 12 |
| Q3 2019 | 4 | 4 | 15 | 8 | 19 |
| Q4 2019 | 4 | 7 | 13 | 10 | 10 |
| Q1 2020 | 7 | 6 | 12 | 3 | 18 |
| Q2 2020 | 3 | 13 | 7 | 6 | 14 |
| Q3 2020 | 3 | 8 | 8 | 5 | 17 |
| Q4 2020 | 16 | 9 | 11 | 6 | 10 |
| Q1 2021 | 40 | 24 | 8 | 10 | -1 |
| Q2 2021 | 33 | 21 | 24 | 19 | -2 |
| Q3 2021 | 23 | 29 | 29 | 14 | 8 |
| Q4 2021 | 10 | 29 | 32 | 19 | 4 |
| Q1 2022 | 9 | 17 | 37 | 17 | 6 |
| Q2 2022 | 17 | 12 | 24 | 33 | -18 |
| Q3 2022 | 14 | 11 | 24 | 13 | 8 |
| Q4 2022 | 15 | 10 | 17 | 20 | 1 |
| Q1 2023 | 1 | 8 | 5 | 12 | 4 |
Hedge funds changes in Infinity Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 654,000 | 135,000 |
|---|---|---|
| Q3 2018 | 1,021,000 | 69,000 |
| Q4 2018 | 211,000 | 22,000 |
| Q1 2019 | 131,000 | 7,000 |
| Q2 2019 | 86,000 | 6,000 |
| Q3 2019 | 37,000 | 0 |
| Q4 2019 | 34,000 | 0 |
| Q1 2020 | 4,000 | 0 |
| Q2 2020 | 4,000 | 0 |
| Q3 2020 | 81,000 | 3,000 |
| Q4 2020 | 275,000 | 282,000 |
| Q1 2021 | 1,657,000 | 1,781,000 |
| Q2 2021 | 2,064,000 | 1,329,000 |
| Q3 2021 | 5,107,000 | 1,656,000 |
| Q4 2021 | 2,876,000 | 655,000 |
| Q1 2022 | 471,000 | 107,000 |
| Q2 2022 | 227,000 | 61,000 |
| Q3 2022 | 482,000 | 111,000 |
| Q4 2022 | 154,564 | 28,677 |
| Q1 2023 | 6,499,000 | 0 |